Financial Info

Financial Highlights  |  Ratios

Valuation P/E 6.95x   P/S 0.85x   P/B 1.17x   EPS 2904.44	Financial Strength Quick Ratio (MRQ) 0.79x   Current Ratio (MRQ) 1.34x   Total Debt/Equity (MRQ) 0.85x   Total Debt/Assets (MRQ) 0.46x	Operating Ratios Assets Turnover (TTM) 0.79x   Inventory Turnover (TTM) 2.85x   Receivables Turnover (TTM) 2.86x
Profitability Gross Margin (TTM) 9.78%   Operating Margin (TTM) 13.01%   EBIT Margin (TTM) 13.66%   Profit Margin (TTM) 13.06%	Management Effectiveness ROA (TTM) 10.28%   ROE (TTM) 19.01%   ROIC (TTM) 3.44%	Growth Rate Diluted EPS Growth (TTM) 61.91%   Sales Growth (TTM) 1.55%   Profit Growth (TTM) 54.53%   Asset Growth (TTM) 14.03%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

The main activity of the Corporation is to invest in member pharmaceutical companies, including the leading pharmaceutical companies in the country. Many enterprises are members of the Corporation have strong financial capacity, extensive distribution network and GMP produced factory with modern technology. The corporation is currently one of only three units authorized...